Viewing StudyNCT00301093



Ignite Creation Date: 2024-05-05 @ 4:45 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00301093
Status: COMPLETED
Last Update Posted: 2020-10-28
First Post: 2006-03-08

Brief Title: Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Sponsor:
Organization: Dana-Farber Cancer Institute